Aloe Drug Claims Land Indian Firm On FDA Import Alert List
This article is powered by The Rose Sheet
Executive Summary
The June 2 update to FDA's list of businesses and their products banned from import also increases the number of Canadian firms identified during 2017 as shipping supplement products that make drug claims or that were made in facilities out of compliance with the agency's good manufacturing practices regulations.
You may also be interested in...
GMP Problems Stop Canadian Firms’ Topical OTC, Homeopathic Imports
Homeolab USA’s and Cellex-C’s imports were stopped earlier in 2017 following GMP inspections at their facilities, and FDA warns that approvals for marketing of additional products in the US could be withheld until each firm is GMP-complaint. Homeolab trips up by trying to prevent FDA photography inside plant.
GMP Problems Stop Canadian Firms’ Topical OTC, Homeopathic Imports
Homeolab USA’s and Cellex-C’s imports were stopped earlier in 2017 following GMP inspections at their facilities, and FDA warns that approvals for marketing of additional products in the US could be withheld until each firm is GMP-complaint. Homeolab trips up by trying to prevent FDA photography inside plant.
Fructis Products From Mexico, South Korea Aloe Gels On FDA Import Alerts
Benton Korea and Ezekiel Cosmetics each shipped 12 products to the US labeled with claims or ingredients, other than aloe, that render them drugs under FDA regulations. Fructis brand hair care products made by two Mexico firms also were detained due to drug claims